Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer

Purpose: Standard chemoradiation therapy for stage III non-small cell lung cancer (NSCLCa) results in suboptimal outcomes with a high rate of local failure and poor overall survival. We hypothesize that dose escalation using stereotactic body radiotherapy (SBRT) boost could improve upon these result...

Descripción completa

Detalles Bibliográficos
Autores principales: Hepel, Jaroslaw T., Peter, Justin, Hiatt, Jessica R., Patel, Salil, Osibanjo, Oluwademilade, Safran, Howard, Curran, Bruce, DiPetrillo, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458262/
https://www.ncbi.nlm.nih.gov/pubmed/23057009
http://dx.doi.org/10.3389/fonc.2012.00124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458262/
https://www.ncbi.nlm.nih.gov/pubmed/23057009
http://dx.doi.org/10.3389/fonc.2012.00124

Ejemplares similares